Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma

Final appraisal determination

Final appraisal determination document (PDF 412 KB)

Committee papers (PDF 2.05 MB)

Public committee slides (PDF 666 KB)

Draft guidance: 1

Appraisal consultation document (PDF 379 KB)

Public committee slides Clinical Effectiveness (PDF 431 KB)

Public committee slides Cost Effectiveness (PDF 531 KB)

Public committee slides Second committee meeting (PDF 754 KB)

Committee papers (PDF 24.12 MB)

Equality impact assessment (Scoping) (PDF 175 KB)

Final scope (PDF 210 KB)

Final matrix (PDF 297 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 196 KB)